CATALOGO DEI PRODOTTI DELLA RICERCA

CICOIRA, Mariantonietta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.728
EU - Europa 5.173
AS - Asia 3.447
SA - Sud America 616
AF - Africa 110
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 15.086
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.631
GB - Regno Unito 1.666
RU - Federazione Russa 1.657
SG - Singapore 1.547
CN - Cina 906
BR - Brasile 505
IT - Italia 340
FR - Francia 329
HK - Hong Kong 307
DE - Germania 280
VN - Vietnam 275
FI - Finlandia 240
IE - Irlanda 235
SE - Svezia 212
KR - Corea 124
UA - Ucraina 101
BD - Bangladesh 51
CA - Canada 42
IN - India 41
NG - Nigeria 40
AR - Argentina 33
TR - Turchia 30
MX - Messico 26
EC - Ecuador 23
ID - Indonesia 23
IQ - Iraq 20
ZA - Sudafrica 20
JP - Giappone 17
BE - Belgio 16
CL - Cile 15
NL - Olanda 15
AT - Austria 12
SA - Arabia Saudita 12
CO - Colombia 11
MA - Marocco 11
PH - Filippine 11
PL - Polonia 11
UZ - Uzbekistan 11
IL - Israele 10
KE - Kenya 10
ES - Italia 9
VE - Venezuela 9
EG - Egitto 8
LT - Lituania 8
PE - Perù 8
PK - Pakistan 8
ET - Etiopia 7
JO - Giordania 7
OM - Oman 7
PY - Paraguay 7
AU - Australia 6
MY - Malesia 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
CZ - Repubblica Ceca 5
DO - Repubblica Dominicana 5
RO - Romania 5
IR - Iran 4
NP - Nepal 4
PA - Panama 4
UY - Uruguay 4
BG - Bulgaria 3
CI - Costa d'Avorio 3
DK - Danimarca 3
DZ - Algeria 3
JM - Giamaica 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MD - Moldavia 3
PS - Palestinian Territory 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
BY - Bielorussia 2
CH - Svizzera 2
DM - Dominica 2
EU - Europa 2
GA - Gabon 2
GR - Grecia 2
LV - Lettonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BZ - Belize 1
CD - Congo 1
CG - Congo 1
CU - Cuba 1
EE - Estonia 1
Totale 15.071
Salva come PNG Salva come JPEG
Città #
Southend 1.516
Singapore 812
Jacksonville 810
Woodbridge 581
Chandler 509
Ashburn 497
San Jose 478
Moscow 444
Dallas 410
Ann Arbor 333
Hong Kong 301
Houston 256
Dublin 234
The Dalles 194
Verona 191
Beijing 161
Lawrence 121
Princeton 121
Wilmington 98
Nanjing 89
Los Angeles 77
Ho Chi Minh City 76
Sindelfingen 66
Buffalo 63
Jinan 62
New York 52
São Paulo 52
Hanoi 51
Abuja 38
Boardman 36
Shenyang 35
Munich 33
Redondo Beach 33
Tianjin 33
Hebei 32
Santa Clara 32
Columbus 31
Milan 28
Changsha 27
Hangzhou 25
Helsinki 23
Zhengzhou 22
Dong Ket 20
Norwalk 20
Guangzhou 19
Nanchang 19
Taiyuan 18
Brussels 16
Ningbo 16
Chicago 15
Frankfurt am Main 15
Fairfield 14
Rio de Janeiro 14
Taizhou 14
Brasília 13
Haikou 13
Haiphong 13
Jiaxing 13
Montreal 13
Turku 13
Council Bluffs 12
Jakarta 12
Tokyo 12
Stockholm 11
Toronto 11
Biên Hòa 10
Düsseldorf 10
Falkenstein 10
Fuzhou 10
London 10
Tashkent 10
Belo Horizonte 9
Bologna 9
Guayaquil 9
Lancaster 9
Nairobi 9
Nuremberg 9
San Francisco 9
Washington 9
Boston 8
Brooklyn 8
Buenos Aires 8
Da Nang 8
Johannesburg 8
Lanzhou 8
Seattle 8
Shanghai 8
Warsaw 8
Addis Ababa 7
Dhaka 7
Mexico City 7
Orem 7
Amman 6
Auburn Hills 6
Campinas 6
City of London 6
Curitiba 6
Denver 6
Falls Church 6
Kent 6
Totale 9.699
Salva come PNG Salva come JPEG
Nome #
Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group 716
Aortic and mitral annular calcification are predictive of all-cause and cardiovascular mortality in patients with type 2 diabetes. 231
Cardiorenal Syndrome Type 1: Pathophysiological Crosstalk Leading to Combined Heart and Kidney Dysfunction in the Setting of Acutely Decompensated Heart Failure. 229
Aortic stiffness correlates with an increased extracellular matrix turnover in patients with dilated cardiomyopathy. 208
Aortic distensibility independently affects exercise tolerance in patients with dilated cardiomyopathy. 199
Additional value of pulmonary vein parameters in defining pseudonormalization of mitral inflow pattern. 179
Increased aortic pulse wave velocity as measured by echocardiography is strongly associated with poor prognosis in patients with heart failure. 173
Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle. 171
A higher body mass index is associated with reduced prevalence of unstable atherosclerotic plaque: A possible explanation of the obesity paradox. 171
Beta-blockers can improve survival in medically-treated patients with severe symptomatic aortic stenosis 171
Alterazioni muscolari e intolleranza allo sforzo nello scompenso cardiaco congestizio: ruolo centrale della periferia 170
Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. 166
Biventricular pacing. 166
The role of angiotensin-converting enzyme polymorphism in congestive heart failure. 161
Relationship between mitral regurgitation and myocardial viability after acute myocardial infarction: their impact on prognosis 161
Association of deranged adrenal steroid metabolism with anemia in chronic heart failure. 160
Echocardiographically Derived Pulse Wave Velocity and Diastolic Dysfunction Are Associated with an Increased Incidence of Atrial Fibrillation in Patients with Systolic Heart Failure 158
Aortic valve sclerosis: a marker of significant obstructive coronary artery disease in patients with chest pain? 157
Determinants of exercise intolerance symptoms considered non-specific for heart failure in patients with stage A and B: role of the left atrium in the transition phase to overt heart failure 157
Body mass index, prognosis and mode of death in chronic heart failure: Results from the Valsartan Heart Failure Trial. 153
Amino-terminal propeptide of type III procollagen is associated with restrictive mitral filling pattern in patients with dilated cardiomyopathy: a possible link between diastolic dysfunction and prognosis. 153
Echocardiographic advances in hypertrophic cardiomyopathy: Three-dimensional and strain imaging echocardiography 153
Left Atrial Volume Provides Independent and Incremental Information Compared With Exercise Tolerance Parameters in Patients With Heart Failure and Left Ventricular Systolic Dysfunction. 152
Aortic valve sclerosis is a marker of atherosclerosis independently of traditional clinical risk factors. Analysis in 712 patients without ischemic heart disease. 152
Skeletal muscle mass independently predicts peak oxygen consumption and ventilatory response during exercise in noncachectic patients with chronic heart failure. 149
Left atrial overload can be used to estimate mitral regurgitant volume. 147
Aortic distensibility independently affects exercise tolerance in patients with dilated cardiomyopathy 146
Predicting heart failure outcome from cardiac and comorbid conditions: The 3C-HF score. 145
Association of aortic valve sclerosis and coronary artery disease in patients with severe nonischemic mitral regurgitation. 143
Aortic stiffness: an old concept for new insights into the pathophysiology of functional mitral regurgitation. 142
Growth hormone resistance in chronic heart failure and its therapeutic implications. 141
Mitral regurgitation and dyspnoea: The expanding role of mitral effective regurgitant orifice among un-selected patients 141
Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure. 138
ESPEN Guidelines on Enteral Nutrition: Cardiology and pulmonology. 138
Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. 137
Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients 135
Relevance of Functional Mitral Regurgitation in Aortic Valve Stenosis 134
Prognostic implications of evaluation of contractile reserve in akinetic and hypokinetic segments during low dose dobutamine echocardiography in patients with acute myocardial infarction. 133
Functional mitral regurgitation in patients with aortic stenosis: prevalence, clinical correlates and pathophysiological determinants: a quantitative prospective study. 133
Ambient air pollution as a new risk factor for cardiovascular diseases: Time to take action 133
Fill in the Gaps of Secondary Mitral Regurgitation: a Continuum Challenge From Pathophysiology to Prognosis 133
Chronic heart failure and cardiac cachexia and links between the endocrine and immune system 132
High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients. 131
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation. 130
Impact of body mass index on short-term outcome after acute myocardial infarction: does excess body weight have a paradoxical protective role? 130
Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy. 128
Identification of High-Risk Chronic Heart Failure Patients in Clinical Practice: Role of Changes in Left Ventricular Function. 126
Mitral regurgitation, left atrial structural and functional remodelling and the effect on pulmonary haemodynamics 126
Carotid atherosclerotic plaque instability in patients with acute myocardial infarction. 124
Myocardial viability independently influences left ventricular diastolic function in the early phase after acute myocardial infarction. 124
Role of growth hormone in chronic heart failure: therapeutic implications 123
Echocardiographic determinants of mortality in patients 67 years of age with chronic heart failure 122
Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype 121
Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia 118
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study 118
Inhibitors of angiotensin-converting enzyme and physical function in older women. 117
Mitral regurgitation and left ventricular diastolic dysfunction similarly affect mitral and pulmonary vein flow Doppler parameters: the advantage of end-diastolic markers. 117
Renal arterial pulsatility predicts progression of chronic kidney disease in chronic heart failure patients. 117
Relation of aldosterone "escape" despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. 116
Role of growth hormone in chronic heart failure 115
Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients. 115
Prognostic value of detection of myocardial viability using low-dose dobutamine echocardiography in infarcted patients 115
Growth hormone treatment in chronic heart failure: lessons from the first 99 patients 114
Chronic heart failure with preserved left ventricular ejection fraction: Diagnostic and prognostic value of left atrial size. 114
Emerging strategies for chronic heart failure: the role of gene therapy 114
Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure. 113
Uric acid and survival in chronic heart failure: validation and application in metabolic, functional and hemodynamic staging. 112
Long-term prognostic value of the stenosis of the infarct-related artery and the presence of viable myocardium in akinetic ventricular regions in infarcted patients 111
Outpatients electrical cardioversion of atrial fibrillation: 8 years' experience. Analysis of shock-related arrhythmias. 111
Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure. 110
Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope. 108
Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition. 108
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 107
Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy. 106
Chronic heart failure in the very elderly: clinical status, survival and prognostic factors in 188 patients more than 70 years old 105
Exercise Performance Is a Prognostic Indicator in Elderly Patients With Chronic Heart Failure--Application of Metabolic Exercise Cardiac Kidney Indexes Score 105
Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not norepinephrine or TNF-alpha 103
Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure. 103
Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration 102
Prediction of mortality in chronic heart failure from peak oxygen consumption adjusted for either body weight or lean tissue. 102
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 101
Role of clinical evaluation and functional testing in the tailored follow-up of chronic heart failure patients 99
Heart failure and anemia: Effects on prognostic variables 99
Heart failure in women treated with adjuvant trastuzumab fro breast cancer. 98
Mitral and aortic valve sclerosis/calcification and carotid atherosclerosis: results from 1065 patients. 98
Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis 97
The influence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure 96
Prognostic relevance of a non-invasive evaluation of right ventricular function and pulmonary artery pressure in patients with chronic heart failure. 95
Obesity paradox in patients with aortic valve stenosis. Protective effect of body mass index independently of age, disease severity, treatment modality and non-cardiac comorbidities. 95
Ischemic etiology of heart failure identifies patients with more severely impaired exercise capacity. 94
Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy. 93
Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure. 93
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison. 93
Effects of ace gene insertion/deletion polymorphism on response to spironolactone in patients with chronic hearth failure. 92
Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow. 92
Prognostic utlity of growth differentiation factor-15 in patients with chronic heart failure 92
Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure 92
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 92
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 91
Progression of Left Ventricular Dysfunction and Remodelling under Optimal Medical Therapy in CHF Patients: Role of Individual Genetic Background. 90
Totale 13.440
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.507
article - articoli 51.507
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.014
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202155 0 0 0 0 0 0 0 0 0 0 0 55
2021/2022723 78 191 18 29 17 28 10 46 23 30 66 187
2022/20231.590 143 119 192 254 156 359 13 119 157 10 46 22
2023/2024659 23 82 58 108 87 71 17 44 3 18 108 40
2024/20252.196 150 162 46 358 75 77 133 114 303 164 146 468
2025/20265.301 448 307 446 837 1.239 356 649 326 324 217 138 14
Totale 15.206